Cervical spondylosis
Conditions
Interventions
Treatment group:Acupuncture combined with electroacupuncture
Control group:Oral administration of celexib capsules
Sponsors
Beijing University of Chinese Medicine Second Affiliated Clinical Hospital Dongfang Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Age 18~75 years old (2)The score of the Visual Analogue Scale (VAS) for the degree of neck pain is = 4 points. (3) Those who have not received treatment related to cervical spondylosis in the past 1 month (4) The acute exacerbation of neck pain or discomfort this time is less than 6 weeks (5) Those who voluntarily participate in this research and sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Those who have had a neck fracture in the past or need surgical intervention (2) Congenital disability skin disease or damage in the neck area; (3) the presence of another serious disease that is not effectively controlled; (4) Unable to complete the questionnaire due to cognitive impairment; (5) pregnant breastfeeding or planning to become pregnant after 6 months; (6) Participate in other clinical trials at the same time. (7)Those with a past history of allergy to Celecoxib capsules and those with contraindications to Celecoxib capsules (such as those with known allergies to sulfonamide drugs and those taking aspirin)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Tenderness threshold;GAD-7;Neck disability index;Neck pain scale;PHQ-9;SF-12;Mechanical pain threshold; | — |
Countries
China
Contacts
Public ContactWlQin
Beijing University of Chinese Medicine Second Affiliated Clinical Hospital Dongfang Hospital
Outcome results
None listed